受强制性开放获取政策约束的文章 - anuradha chougule了解详情
可在其他位置公开访问的文章：10 篇
Effective management of advanced angiosarcoma by the synergistic combination of propranolol and vinblastine-based metronomic chemotherapy: a bench to bedside study
E Pasquier, N André, J Street, A Chougule, B Rekhi, J Ghosh, DSJ Philip, ...
EBioMedicine 6, 87-95, 2016
强制性开放获取政策： Australian Research Council, National Health and Medical Research Council …
Actionable activating oncogenic ERBB2/HER2 transmembrane and juxtamembrane domain mutations
KB Pahuja, TT Nguyen, BS Jaiswal, K Prabhash, TM Thaker, K Senger, ...
Cancer cell 34 (5), 792-806. e5, 2018
强制性开放获取政策： US National Institutes of Health, Howard Hughes Medical Institute, Susan G …
Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity
A Chougule, K Prabhash, V Noronha, A Joshi, A Thavamani, P Chandrani, ...
PloS one 8 (10), e76164, 2013
强制性开放获取政策： Department of Biotechnology, India, Wellcome Trust
EGFR Mutations in Indian Lung Cancer Patients: Clinical Correlation and Outcome to EGFR Targeted Therapy
V Noronha, K Prabhash, A Thavamani, A Chougule, N Purandare, A Joshi, ...
PLoS One 8 (4), e61561, 2013
强制性开放获取政策： Department of Biotechnology, India, Wellcome Trust
Repeat biopsy in epidermal growth factor receptor mutation-positive nonsmall cell lung cancer: Feasibility, limitations, and clinical utility in Indian patients
S Zanwar, V Noronha, A Joshi, VM Patil, A Chougule, R Kumar, S More, ...
Indian Journal of Cancer 54 (1), 280-284, 2017
强制性开放获取政策： US National Institutes of Health
Molecular tumor board–guided treatment of non-small-cell lung cancer with dual driver (ALK and EGFR) alterations
V Behel, V Noronha, V Patil, N Menon, P Chandrani, R Kumar, S Rastogi, ...
Cancer Research, Statistics, and Treatment 5 (2), 312-316, 2022
强制性开放获取政策： Wellcome Trust/DBT India Alliance
Deep-Learning-Based Predictive Imaging Biomarker Model for EGFR Mutation Status in Non-Small Cell Lung Cancer from CT Imaging
A Mahajan, V Kania, U Agarwal, R Ashtekar, S Shukla, VM Patil, ...
Cancers 16 (6), 1130, 2024
强制性开放获取政策： Department of Biotechnology, India
Integrated proteomics and phosphoproteomics revealed druggable kinases in neoadjuvant chemotherapy resistant tongue cancer
IA George, G Sathe, V Ghose, A Chougule, P Chandrani, V Patil, ...
Frontiers in Cell and Developmental Biology 10, 957983, 2022
强制性开放获取政策： Council of Scientific and Industrial Research, India
RET Alterations Differentiate Molecular Profile of Medullary Thyroid Cancer
K Prabhash, E Saldanha, V Patil, M Bal, S Reddy P, A Sanjeev, R Kumar, ...
JCO Precision Oncology 8, e2300622, 2024
强制性开放获取政策： Department of Biotechnology, India, Department of Science & Technology, India
Real-World Evidence of EGFR Targeted Therapy in NSCLC–A Brief Report of Decade Long Single Center Experience
A Chougule, P Chandrani, V Noronha, P Pange, S Kale, A Nikam, ...
JTO Clinical and Research Reports 4 (11), 100566, 2023
强制性开放获取政策： Department of Biotechnology, India, Department of Science & Technology, India
出版信息和资助信息由计算机程序自动确定